Novel human ion-exchanger proteins and polynucleotides encoding the same

• US 20050059050A1
• Filed: 07/07/2004
• Published: 03/17/2005
• Est. Priority Date: 09/27/2000
• Status: Active Grant

• Current Assignee: Brenda Gerhardt, Carl Johan Friddle
• Original Assignee: Brenda Gerhardt, Carl Johan Friddle
• Inventors: Friddle, Carl Johan, Gerhardt, Brenda
• Granted Patent: US 7,057,029 B2
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: C07K 14/705 Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/4748

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims

1-5. -5. (cancelled)

6. An isolated polypeptide comprising an amino acid sequence drawn from the group consisting of SEQ ID NOS:

2, 4 and 6.

7. An antibody having immunospecificity for the polypeptide sequence drawn from the group consisting of SEQ ID NOS:

2, 4 and 6.